Arcturus Therapeutics (ARCT) Stock Chart & Stock Price History $21.25 +1.86 (+9.59%) Closing price 04:00 PM EasternExtended Trading$21.32 +0.07 (+0.35%) As of 05:06 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipShort InterestTrendsBuy This Stock Arcturus Therapeutics Stock Price Performance The Arcturus Therapeutics (ARCT) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 1.58%, with a year-to-date return of 25.22%. In the past month, the stock has increased 22.69%, reflecting recent market activity. As of the latest close, Arcturus Therapeutics traded at $19.39 with a market cap of $526.63 million and volume of 599,317 shares. Five years ago, the stock traded at $51.57, representing a 58.79% decrease over that period. At the time, it had a market cap of $1.26 billion and a volume of 281,786 shares. Receive ARCT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Arcturus Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. 5 Day Performance+7.98%1 Month Performance+22.69%3 Month Performance+59.65%Year-To-Date Performance+25.22%1 Year Performance+1.58%5 Year Performance-58.79% ARCT Stock Chart for Tuesday, October, 14, 2025 ARCT Chart by TradingView Arcturus Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization10/13/2025$18.95$19.39+2.32%$19.81$18.79599,317 shs$526.63 million10/10/2025$19.68$18.95-3.71%$20.25$18.37949,446 shs$514.68 million10/09/2025$21.20$19.68-7.17%$21.19$19.621.04 million shs$534.41 million10/08/2025$20.47$21.20+3.57%$21.25$19.46982,720 shs$575.79 million10/07/2025$21.01$20.47-2.57%$21.59$20.20754,735 shs$555.97 million10/06/2025$22.56$21.01-6.87%$22.92$20.721.48 million shs$570.53 million10/03/2025$21.88$22.56+3.11%$23.60$20.081.68 million shs$612.62 million10/02/2025$20.48$21.88+6.84%$21.94$20.46680,059 shs$594.26 million10/01/2025$18.43$20.48+11.12%$21.27$18.801.14 million shs$556.24 million09/30/2025$18.78$18.43-1.86%$19.05$17.92629,108 shs$500.47 million Get the Latest News and Ratings for ARCT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Arcturus Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 09/29/2025$22.17$18.78-15.29%$22.13$18.741.43 million shs$510.07 million09/26/2025$20.31$22.17+9.16%$22.40$20.51915,025 shs$602.14 million09/25/2025$20.45$20.31-0.68%$20.50$19.56413,470 shs$551.62 million09/24/2025$20.26$20.45+0.94%$21.32$20.40421,285 shs$555.32 million09/23/2025$21.03$20.26-3.66%$21.26$20.18772,165 shs$550.26 million09/22/2025$20.46$21.03+2.79%$21.66$20.18682,431 shs$571.18 million09/19/2025$19.62$20.46+4.28%$20.79$19.531.12 million shs$555.69 million09/18/2025$18.05$19.62+8.70%$19.69$18.261.11 million shs$532.78 million09/17/2025$18.09$18.05-0.22%$18.58$17.70581,928 shs$490.24 million09/16/2025$18.13$18.09-0.22%$19.50$17.83927,027 shs$491.32 million09/15/2025$17.32$18.13+4.68%$18.21$17.25411,791 shs$492.32 million Related Companies IDEAYA Biosciences Stock Price Chart Belite Bio Stock Price Chart ImmunityBio Stock Price Chart Arcutis Biotherapeutics Stock Price Chart Recursion Pharmaceuticals Stock Price Chart Mesoblast Stock Price Chart Disc Medicine Stock Price Chart Agios Pharmaceuticals Stock Price Chart Denali Therapeutics Stock Price Chart Sarepta Therapeutics Stock Price Chart Receive ARCT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Arcturus Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ARCT) was last updated on 10/14/2025 by MarketBeat.com Staff From Our PartnersNEW LAW: Congress Approves Setup For Digital Dollar?Trump Ally Says Congress Approved the Setup for a Digital Dollar 2.0 But according to Rep. Marjorie Taylor ...Goldco Precious Metals | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredNvidia’s slow death marchEric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredWhy Wall Street is piling into the “Debasement Trade”Wall Street is piling into what insiders are calling the “Debasement Trade” — and according to former Goldman ...Stansberry Research | Sponsored2 Nobel Prize winners warn of once-in-a-generation wealth shift…An unstoppable force is reshaping America — one so powerful it’s already disrupting how we work, invest, and l...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Arcturus Therapeutics Holdings Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Arcturus Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
